Viridian Therapeutics
Price & Volume
Stats
See more52W Range | $11.76-$34.29 |
Market Cap | $1.4B |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $70.8M |
Revenue Growth (YoY) | 83.3% |
Gross Profit (12 Mos) | -$268M |
Diluted EPS | -$3.32 |
News
See moreYahoo Finance • 2 days ago
Viridian Therapeutics price target lowered to $36 from $40 at Truist
Yahoo Finance • 3 days ago
Viridian Metals Secures $225,000 Maximum JEA Funding; Adopts Quarterly Reporting Exemption
Yahoo Finance • 4 days ago
Stifel sees path towards differentiation for Viridian after Amgen data
Yahoo Finance • 11 days ago
Morning Movers: Sysco dips following deal to acquire Jetro Restaurant Depot
About
CEO | Mr. Stephen F. Mahoney J.D., MBA |
Address | 221 Crescent Street, Waltham, MA, United States, 02453 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 252 |
